NeuroSense Net Receivables vs Total Current Liabilities Analysis

NRSNW Stock  USD 0.25  0.13  34.21%   
NeuroSense Therapeutics financial indicator trend analysis is infinitely more than just investigating NeuroSense Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NeuroSense Therapeutics is a good investment. Please check the relationship between NeuroSense Therapeutics Net Receivables and its Total Current Liabilities accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroSense Therapeutics Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy NeuroSense Stock please use our How to Invest in NeuroSense Therapeutics guide.

Net Receivables vs Total Current Liabilities

Net Receivables vs Total Current Liabilities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NeuroSense Therapeutics Net Receivables account and Total Current Liabilities. At this time, the significance of the direction appears to have strong relationship.
The correlation between NeuroSense Therapeutics' Net Receivables and Total Current Liabilities is 0.76. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of NeuroSense Therapeutics Ltd, assuming nothing else is changed. The correlation between historical values of NeuroSense Therapeutics' Net Receivables and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of NeuroSense Therapeutics Ltd are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Net Receivables i.e., NeuroSense Therapeutics' Net Receivables and Total Current Liabilities go up and down completely randomly.

Correlation Coefficient

0.76
Relationship DirectionPositive 
Relationship StrengthSignificant

Net Receivables

Total Current Liabilities

Total Current Liabilities is an item on NeuroSense Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of NeuroSense Therapeutics Ltd are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from NeuroSense Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NeuroSense Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroSense Therapeutics Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy NeuroSense Stock please use our How to Invest in NeuroSense Therapeutics guide.Enterprise Value is likely to climb to about 12.9 M in 2024, whereas Selling General Administrative is likely to drop slightly above 3.3 M in 2024.

NeuroSense Therapeutics fundamental ratios Correlations

0.550.460.740.5-0.95-0.520.330.950.42-0.841.00.870.44-0.510.950.720.60.740.51.00.85-0.25-0.460.24
0.550.99-0.140.82-0.39-1.00.970.430.79-0.890.520.820.97-0.930.750.90.98-0.140.830.530.03-0.85-0.950.86
0.460.99-0.240.79-0.3-0.990.990.350.77-0.840.430.760.97-0.920.670.860.97-0.240.810.44-0.07-0.89-0.950.9
0.74-0.14-0.240.06-0.770.15-0.380.72-0.01-0.30.750.4-0.210.070.550.2-0.091.00.040.750.980.460.16-0.47
0.50.820.790.06-0.27-0.850.720.251.0-0.80.460.720.89-0.960.740.910.720.061.00.480.14-0.45-0.930.47
-0.95-0.39-0.3-0.77-0.270.36-0.19-0.99-0.170.73-0.95-0.81-0.220.27-0.84-0.58-0.49-0.77-0.27-0.95-0.890.130.23-0.13
-0.52-1.0-0.990.15-0.850.36-0.96-0.39-0.830.88-0.49-0.81-0.980.95-0.74-0.91-0.970.15-0.87-0.51-0.020.820.97-0.84
0.330.970.99-0.380.72-0.19-0.960.240.72-0.760.30.670.95-0.870.560.780.95-0.380.750.31-0.21-0.92-0.920.93
0.950.430.350.720.25-0.99-0.390.240.16-0.740.950.820.26-0.290.840.580.540.720.260.950.85-0.22-0.260.22
0.420.790.77-0.011.0-0.17-0.830.720.16-0.740.380.650.88-0.950.670.870.68-0.010.990.390.06-0.44-0.920.46
-0.84-0.89-0.84-0.3-0.80.730.88-0.76-0.74-0.74-0.82-0.97-0.820.84-0.96-0.95-0.91-0.3-0.81-0.83-0.460.60.83-0.61
1.00.520.430.750.46-0.95-0.490.30.950.38-0.820.860.4-0.470.930.690.570.750.461.00.86-0.23-0.430.22
0.870.820.760.40.72-0.81-0.810.670.820.65-0.970.860.71-0.740.970.940.860.40.730.860.56-0.5-0.720.51
0.440.970.97-0.210.89-0.22-0.980.950.260.88-0.820.40.71-0.980.670.870.91-0.210.90.42-0.08-0.81-1.00.82
-0.51-0.93-0.920.07-0.960.270.95-0.87-0.29-0.950.84-0.47-0.74-0.98-0.74-0.91-0.850.07-0.96-0.48-0.040.690.99-0.7
0.950.750.670.550.74-0.84-0.740.560.840.67-0.960.930.970.67-0.740.910.770.550.740.940.68-0.39-0.70.4
0.720.90.860.20.91-0.58-0.910.780.580.87-0.950.690.940.87-0.910.910.880.20.920.70.34-0.54-0.890.56
0.60.980.97-0.090.72-0.49-0.970.950.540.68-0.910.570.860.91-0.850.770.88-0.090.740.590.1-0.86-0.880.87
0.74-0.14-0.241.00.06-0.770.15-0.380.72-0.01-0.30.750.4-0.210.070.550.2-0.090.040.750.980.460.16-0.47
0.50.830.810.041.0-0.27-0.870.750.260.99-0.810.460.730.9-0.960.740.920.740.040.470.12-0.47-0.930.49
1.00.530.440.750.48-0.95-0.510.310.950.39-0.831.00.860.42-0.480.940.70.590.750.470.86-0.24-0.440.23
0.850.03-0.070.980.14-0.89-0.02-0.210.850.06-0.460.860.56-0.08-0.040.680.340.10.980.120.860.290.03-0.29
-0.25-0.85-0.890.46-0.450.130.82-0.92-0.22-0.440.6-0.23-0.5-0.810.69-0.39-0.54-0.860.46-0.47-0.240.290.75-1.0
-0.46-0.95-0.950.16-0.930.230.97-0.92-0.26-0.920.83-0.43-0.72-1.00.99-0.7-0.89-0.880.16-0.93-0.440.030.75-0.76
0.240.860.9-0.470.47-0.13-0.840.930.220.46-0.610.220.510.82-0.70.40.560.87-0.470.490.23-0.29-1.0-0.76
Click cells to compare fundamentals

NeuroSense Therapeutics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for NeuroSense Stock Analysis

When running NeuroSense Therapeutics' price analysis, check to measure NeuroSense Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuroSense Therapeutics is operating at the current time. Most of NeuroSense Therapeutics' value examination focuses on studying past and present price action to predict the probability of NeuroSense Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuroSense Therapeutics' price. Additionally, you may evaluate how the addition of NeuroSense Therapeutics to your portfolios can decrease your overall portfolio volatility.